Markers of Severe CRS and ICANS in Patients With B-Cell ALL Receiving CAR T-Cell Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Syndrome in B-Cell ALL Patients Receiving CART19
Clin. Cancer Res 2022 Jun 15;[EPub Ahead of Print], C Diorio, R Shraim, R Myers, EM Behrens, S Canna, H Bassiri, R Aplenc, C Burudpakdee, F Chen, AM DiNofia, S Gill, V Gonzalez, MP Lambert, A Barz Leahy, BL Levine, RB Lindell, SL Maude, JJ Melenhorst, H Newman, J Perazzelli, AE Seif, SF Lacey, CH June, DM Barrett, SA Grupp, DT TeacheyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.